Diagnosis and treatment of passenger lymphocyte syndrome following secondary ABO-incompatible allogeneic hematopoietic stem cell transplantation
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 11
Abstract
Objective To investigate the clinical characteristics and diagnosis and treatment of passenger lymphocyte syndrome (PLS) in patients following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods A total of 489 patients who underwent allo-HSCT in Suzhou Hongci Hematology Hospital were retrospectively enrolled. The clinical process, diagnosis and treatment measures and prognosis of four patients complicated with PLS after transplantation were analyzed. Results Among the 489 patients, 4 were diagnosed with PLS. The blood types of donor/recipient ABO were all secondary incompatible (The blood type of donors were O and the recipients were A or B). The overall incidence of PLS in allo-HSCT was 0.82%(4/489)and 2.2%(4/179)in transplants with donor/recipient secondary incompatible ABO-blood types. PLS occured in 6-13 days after donor stem cell infusion. Clinical manifestations were dizziness and fatigue, low back pain, jaundice, deepening urine, rapid decrease in hemoglobin on laboratory tests, elevated indirect bilirubin and lactate dehydrogenase, positive urobilinogen, positive direct anti-human globulin test (DAT), and anti-A or anti-B antibodies against recipient red blood cells were detected in plasma. After the treatment of O-type washed red blood cells, methylprednisolone, gamma globulin, rituximab and other treatments, the hemolysis was improved. All patients achieved engraftment of neutrophil and platelet. Red blood cell transfusion was halted in 3 weeks. Conclusion PLS is a rare complication of allo-HSCT, which mainly occurs in allo-HSCT patients with secondary incompatibility of ABO blood group of donor/recipient. The clinical prognosis is good after properly treatment.
Authors and Affiliations
Yingchun SHAO, Shiyuan ZHOU, Qian ZHU, Guanggang DOU, Xiao MA, Xiaojin WU, Chao MA
Keywords
Related Articles
- EP ID EP738685
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.11.005
- Views 33
- Downloads 0
Preparation and preliminary evaluation of sodium alginate/agarose/carboxymethyl chitosan spray film dressing carrying platelet rich plasma for wound repair
Objective To develop a spray-on membrane dressing for wound repair containing platelet rich plasma (PRP) sodium alginate (SA)/agarose(AG)/carboxymethyl chitosan (CMCS). Methods SA/AG/ CMCS were mixed in different proport...
Optimization of large-scale production process for human prothrombin complex concentrates
Objective To determine the optimal process conditions for efficiently extracting human prothrombin complex concentrates from human plasma. Methods Using human plasma as the materials and the yield of prothrombin complex...
Blood transfusion adverse event management system: construction and application
Objective To establish a blood transfusion adverse event management system and apply it to adverse events management, so as to enhance the ability to identify and process reports as well as prevent adverse events. Method...
Identification of B(A) subtype and analysis of bood transfusion strategiaes
Objective To investigate the serology and genotype identification method of B (A) subtype patients. Methods Test tube method (serology) was used to confirm the clinically difficult ABO blood group samples of 3 patients w...
Construction of a consistency evaluation system for a nucleic acid testing kit: a preliminary study
Objective To evaluate the performance of a blood nucleic acid testing kit, construct a consistency assessment system, and analyze the influencing factors of the test results. Methods A total of 18 644 samples of voluntar...